UBS Cuts American Healthcare REIT (AHR) Price Target to $62

UBS reaffirms its Buy rating on American Healthcare REIT, Inc. with a target price of $62.00, a 16.77% upside from the current price.

By TradeTexts Research Desk · Published Oct 16, 2026, 2:31 PM EDT

Reviewed by automated data checks against the source data. How we make and check alerts

UBS cut its price target on American Healthcare REIT, Inc. ($AHR) to $62 from $63 on October 13, 2026, and rates the stock "Buy".

Since the rating, $AHR is up 1.3% to date (from the $52.53 close on Oct 13, 2026).

AHR American Healthcare REIT, Inc.

$53.23 +14.37% year to date

Daily close · Oct 16, 2026

Key Points

On October 13, 2026, UBS reiterated its Buy rating on American Healthcare REIT, Inc. with a price target of $62.00, down from $63.00.
Shares of American Healthcare REIT, Inc. closed at $52.53 on the same day, and recently traded at $53.09, about 1.1% above the event close.
The stock currently trades below the mean analyst target of $63.69, indicating potential upside for investors.

Get $AHR trade alerts by text

We text you when insiders, Congress or big funds trade $AHR. Free.

Not investment advice. TradeTexts is not a registered investment adviser, and this automated American Healthcare REIT, Inc. alert may contain errors. Disclosures

UBS has reiterated its Buy rating on American Healthcare REIT, Inc. (AHR) with a new price target of $62.00, down from $63.00. This update came on October 13, 2026, the same day AHR closed at $52.53. As of October 16, 2026, the stock was recently trading around $53.09, which is 1.1% above the closing price on the rating date.

Analyst rating track record

UBS vs. the S&P 500

YTD return -2.09% hypothetical

All-time return -2.09% S&P 500 +0.79%

vs. S&P 500 -2.88% behind the index

Hypothetical returns from UBS's disclosed trades, not real profit or advice. How we model this.

Other Institutional Activity in American Healthcare REIT, Inc.

Several other institutional investors have adjusted their positions in American Healthcare REIT. Blackrock Inc. reduced its stake by 2,894,125 shares, bringing its total to 25,845,948 shares valued at approximately $1.38 billion. Meanwhile, Vanguard Portfolio Management LLC increased its holdings by 851,352 shares, ending with 16,975,438 shares worth about $903.9 million. Additionally, Vanguard Capital Management LLC added 1,002,723 shares, totaling 9,201,599 shares valued at around $490 million. State Street Corporation trimmed its position by 499,216 shares, now holding 9,046,025 shares valued at about $481.7 million. Principal Financial Group, Inc. grew its stake by 1,494,973 shares, ending with 8,917,875 shares worth about $474.9 million.

American Healthcare REIT, Inc. Stock Up 0.2%

Currently, AHR shares are trading above their 52-week low of $41.67 but below the 52-week high of $58.70. The stock is about 27.4% above its 52-week low and approximately 9.6% below its highest point over the past year. While the recent trading price is above the event close, it remains below the 50-day moving average of $53.53 and the mean analyst price target of $63.69.

12-month forecast

$AHR price target

American Healthcare REIT, Inc. daily closes and this analyst's $62 target. Not advice.

Recent Earnings

American Healthcare REIT reported trailing twelve-month revenue of approximately $2.5 billion, with an earnings per share (EPS) of $0.67. The company has shown a revenue growth of 24.7% year-over-year, and its next earnings report is scheduled for November 5, 2026.

Insider Buying and Selling at American Healthcare REIT, Inc.

Recent insider transactions show that Mark E. Foster, General Counsel, sold 2,500 shares on June 24, 2026, at an average price of $48.58, totaling $121,450. On June 26, 2026, Chief Financial Officer Brian Scott Peay sold 25,000 shares for $1,267,402 at an average price of $50.70. Foster made additional sales of 2,000 shares on September 1 at $55.39, worth $110,780, and 1,500 shares on September 25 at $52.06, totaling $78,090.

Analysts Set New Price Targets

On October 13, 2026, UBS maintained its Buy rating on American Healthcare REIT with a price target of $62.00. The firm had previously set the target at $63.00. Also, on the same day, Barclays maintained an Overweight rating with a target of $60.00, while Raymond James initiated coverage with a Strong Buy rating at a target of $62.00. The consensus price target among analysts is $63.69, based on 16 opinions, indicating a strong buy recommendation.

About American Healthcare REIT, Inc.

American Healthcare REIT, Inc. is a self-managed real estate investment trust (REIT) based in Maryland. It owns and operates a diverse portfolio of healthcare-related properties, including senior housing and skilled nursing facilities across the U.S., U.K., and the Isle of Man. The company utilizes a fully integrated management platform to enhance its operations.

Bottom Line

Investors should keep an eye on AHR's next earnings report on November 5, 2026, and monitor any further updates from analysts. With shares trading below the analyst target, there may be opportunities for investors looking at this REIT.